The Respire Institute

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• COPD1 trial
• Cystic fibrosis1 trial

Phase

• Phase 21 trial

Status

• Recruiting2 trials

Lead sponsor

• Sanofi1 trial
• Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 trial

Running trials

• Recruiting

  The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

  NCT07612878· Sanofi· Source

  Contact: Janeth Rodriguez

• Recruiting

  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

  NCT06559150· Phase 2· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

  Contact: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway Toll Free Number

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting
• COPD1 recruiting
• Cystic fibrosis1 recruiting